Formerly believed to predominantly affect Caucasians, new research indicates that MS actually may hit Blacks the hardest.
Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...
Multiple sclerosis (MS) is a disease of the central nervous system. More than 2.8 million people worldwide live with MS, according to the Multiple Sclerosis International Federation. MS is an ...
Relapsing-remitting multiple sclerosis is a type of multiple sclerosis ... MS is a chronic, progressive condition of the central nervous system (CNS) in which your immune system attacks myelin ...
A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...
GlobalData on MSN6d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis casesTeva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
News Medical on MSN13d
Pheno Therapeutics receives clinical trial authorization for novel multiple sclerosis therapeuticPheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback